Caribou Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -9.92 | -100% |
| P/S |
|
13.19 | 33.77 | -60.95% |
|
|
| P/BV |
|
1.23 | 4.83 | -74.44% |
|
|
| P/FCF |
|
-5.13 | 61 | -108.4% |
|
|
| Ev/Ebitda |
|
-3.83 | -22.17 | -82.72% |
|
|
| Ev/S |
|
12.5 | 22.57 | -44.62% |
|
|
| Ev/FCF |
|
-4.11 | 68.76 | -105.97% |
|
|
| E/P |
|
-0.1898 | 0.0178 | -1167.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-326.4 | 4.97 | -6664.73% | -531.96 | -38.64% |
| ROE |
|
-27.71 | 9.61 | -388.26% |
|
|
| ROA |
|
-23.15 | 0.3443 | -6823.65% |
|
|
| ROIC |
|
-39.84 | 7.63 | -621.85% |
|
|
| ROS |
|
-296.05 | -25.17 | 1076.2% |
|
|
| ROCE |
|
-31.5 | 15.45 | -303.91% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2442 | -3.68 | -93.36% | -0.1996 | +22.37% |
| Nеt Debt/Ebitda |
|
0.2104 | -3.44 | -106.12% |
|
|
| Debt/Ratio |
|
0.0623 | 0.1986 | -68.61% |
|
|
| Debt/Equity |
|
2.57 | 1.66 | 54.52% |
|
|
| Debt/Net Income |
|
-0.2693 | 10.32 | -102.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
474.62 | -57.64 | -923.42% | ||
| Growth impulse Ebitda in 5 years |
|
272.47 | -90.94 | -399.62% | ||
| Growth impulse Net Income in 5 years |
|
343.78 | -97.8 | -451.51% | ||
| Growth impulse FCF in 5 years |
|
217.89 | -108.72 | -300.41% | ||
| Growth impulse EPS in 5 years |
|
34.26 | -142.05 | -124.12% |
IP Score
4.53/10
